Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01759381 · ClinicalTrials.gov registry record · NA

Incisional Negative Pressure Wound Therapy

A NA study, sponsored by Duke University.

Terminated
Registry status
NA
Development phase
19
Enrollment target

NCT01759381: Clinical Trial NA study, sponsored by Duke University.

NCT01759381 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01759381, a NA study, was terminated before completion, sponsored by Duke University.

TERMINATED
Registry status
NA
Development phase
19 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the outcome of incisional negative pressure wound therapy in preventing surgical site infections and wound complications (dehiscence) in high-risk patients undergoing complex spinal surgery.

Primary Outcome

The patient will be assessed for signs/symptoms of infection within the 3 month post-operative period.

Interventions

  • DEVICE Negative pressure wound therapy (NPWT)

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2012-12
Est. Completion 2015-06
Phase NA
Duke University

1,725 total trials

Why NCT01759381 stopped before completion

NCT01759381 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Negative pressure wound therapy (NPWT) is the first listed.

NCT01759381 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01759381 about?

NCT01759381 is a clinical study titled "Incisional Negative Pressure Wound Therapy". The purpose of this study is to evaluate the outcome of incisional negative pressure wound therapy in preventing surgical site infections and wound complications (dehiscence) in high-risk patients undergoing complex spinal surgery.

What is the current status of trial NCT01759381?

This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2012-12. Estimated completion is 2015-06.

What interventions are being tested in trial NCT01759381?

The interventions under investigation include: Negative pressure wound therapy (NPWT) (DEVICE).

Who is sponsoring clinical trial NCT01759381?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01759381's enrollment target sits among peer trials

19 1861st of 2000 higher than 138 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01759381, the US trial registry maintained by the National Library of Medicine. NCT01759381 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.